Delivery Order SPE2DB20D3101-SPE2DB25FRDK5

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for TRESIBA FLEXTOUCH 100 UNIT/ML 3ML. The contract has a firm fixed price of $2,782.23 and a completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
The federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $10,369.20 and is a firm-fixed-price delivery order with a completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,001.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $11,864.96. The contract is a delivery order with a firm fixed price and has a period of performance through February 23, 2024. It was awarded on February 22, 2024, and does not have a set-aside designation,...
This federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $10,184.64, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of November 26, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products. The contract has a ceiling value of $2,289.66 and a period of performance through April 12, 2024. This delivery order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,652.15 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 29, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,803,876 units of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML. The delivery order is valued at $6,882.90 and has a completion date of February 29, 2024. This award is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order (SPE2DB24FKGLW) valued at $21,886.95 for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products to the government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. This contract is not set aside for any specific business type. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRDK5
    Delivery Order

This contract award is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,384.20. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/2/25, 10:00 AM